Inverness Expands Diagnostics Focus To Cardiac R&D
This article was originally published in The Gray Sheet
Executive Summary
Inverness Medical Innovations plans to initiate a cardiac diagnostics portfolio with a home-use prothrombin test launch at the end of 2004
You may also be interested in...
Inverness’ Wampole Labs Adds Rapid HIV Test To Point-Of-Care Offerings
Wampole will compete with Orasure in the physician office and point-of-care (PoC) rapid HIV testing market under an exclusive U.S. distribution pact with Efoora for its Rapid HIV test
Inverness Builds Sales With Consumer Products, Acquires Apogent Unit
Inverness Medical Innovations expects its newly acquired Applied Biotech diagnostics business to add about $20 mil. to annual revenues
Inverness Finds New Revenue Stream Following Pfizer Settlement
Inverness Medical's pregnancy test patent litigation settlement with Pfizer may lead to future collaborations between the firms related to the contended technology